Pfizer lifts curtain on $740M+ extension at API manufacturing site in Singapore
To further entrench its roots in Singapore, Pfizer has opened the doors to a facility extension at a local plant to boost API production for …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
